Valuation: Novartis AG

Market Cap 29TCr 26TCr 24TCr 22TCr 41TCr 26,62300Cr 43TCr 2,93700Cr 1,16700Cr 14,54100Cr 1,07900Cr 1,05600Cr 45,63700Cr P/E 2026 *
23x
P/E 2027 * 18x
Enterprise Value 32TCr 29TCr 27TCr 25TCr 46TCr 29,73000Cr 48TCr 3,27900Cr 1,30300Cr 16,23900Cr 1,20500Cr 1,17900Cr 50,96300Cr EV / Sales 2026 *
5.56x
EV / Sales 2027 * 5.12x
Free-Float
91.66%
Yield 2026 *
2.87%
Yield 2027 * 3.01%

Last Transcript: Novartis AG

1 day+0.41%
1 week-4.70%
Current month-4.50%
1 month+0.69%
3 months+0.27%
6 months+7.15%
Current year+16.57%
1 week 126.76
Extreme 126.76
137
1 month 125.38
Extreme 125.38
137
Current year 107.68
Extreme 107.68
137
1 year 102.56
Extreme 102.56
137
3 years 81.1
Extreme 81.1
137
5 years 72.84
Extreme 72.84
137
10 years 65.09
Extreme 65.09
137
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-4.70%+24.18%+50.18% 29TCr
-0.30%-6.68%+27.12%+127.32% 1,20000Cr
+1.25%-5.35%+32.65%+78.98% 65TCr
+0.94%-2.99%+21.13%+106.30% 51TCr
-0.60%-1.95%+25.73%+67.00% 38TCr
+0.69%-9.50%+36.78%+30.83% 33TCr
+0.81%-4.08%-2.95%+31.59% 27TCr
-0.15%-6.45%+29.06%+65.76% 24TCr
-0.06%-0.98%+31.42%+122.83% 21TCr
-0.25%-5.01%-13.18%-62.25% 17TCr
Average +0.27%-4.78%+21.19%+61.85% 42TCr
Weighted average by Cap. +0.28%-5.18%+24.44%+81.81%

Financials

2026 *2027 *
Net sales 5.78TCr 5.26TCr 4.85TCr 4.41TCr 8.27TCr 5,34800Cr 8.69TCr 59TCr 23TCr 2,92100Cr 22TCr 21TCr 9,16700Cr 6.17TCr 5.62TCr 5.18TCr 4.71TCr 8.84TCr 5,71300Cr 9.29TCr 63TCr 25TCr 3,12100Cr 23TCr 23TCr 9,79400Cr
Net income 1.27TCr 1.16TCr 1.07TCr 973.14Cr 1.83TCr 1,18000Cr 1.92TCr 13TCr 5.18TCr 64TCr 4.78TCr 4.68TCr 2,02300Cr 1.57TCr 1.43TCr 1.32TCr 1.2TCr 2.25TCr 1,45200Cr 2.36TCr 16TCr 6.37TCr 79TCr 5.88TCr 5.76TCr 2,48900Cr
Net Debt 3.36TCr 3.06TCr 2.82TCr 2.56TCr 4.81TCr 3,10700Cr 5.05TCr 34TCr 14TCr 1,69700Cr 13TCr 12TCr 5,32600Cr 2.83TCr 2.58TCr 2.38TCr 2.16TCr 4.06TCr 2,62500Cr 4.27TCr 29TCr 12TCr 1,43400Cr 11TCr 10TCr 4,49900Cr
Projected Income Statement - Annual - Novartis AG
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
20/26/20 CHF 127.76 +0.41% 41,44,754
19/26/19 CHF 127.24 -3.22% 51,29,526
18/26/18 CHF 131.48 -1.35% 30,12,676
17/26/17 CHF 133.28 -1.83% 25,22,765
16/26/16 CHF 135.76 +1.27% 18,75,146
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Novartis AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
152.23USD
Average target price
153.39USD
Spread / Average Target
+0.76%
  1. Stock Market
  2. Stocks
  3. NOVN Stock